Cargando…

GM-CSF as a therapeutic target in autoimmune diseases

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been known as a hematopoietic growth factor and immune modulator. Recent studies revealed that GM-CSF also had pro-inflammatory functions and contributed to the pathogenicity of Th17 cells in the development of Th17-mediated autoimmune di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiomi, Aoi, Usui, Takashi, Mimori, Tsuneyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725926/ https://www.ncbi.nlm.nih.gov/pubmed/29259681 http://dx.doi.org/10.1186/s41232-016-0014-5

Ejemplares similares

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

GM-CSF: A Promising Target in Inflammation and Autoimmunity
por: Lee, Kevin M C, et al.
Publicado: (2020)

Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
por: Lotfi, Noushin, et al.
Publicado: (2019)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
por: Borriello, Francesco, et al.
Publicado: (2019)

GM-CSF-Producing Th Cells in Rats Sensitive and Resistant to Experimental Autoimmune Encephalomyelitis
por: Stojić-Vukanić, Zorica, et al.
Publicado: (2016)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Overexpression of a Minimal Domain of Calpastatin Suppresses IL-6 Production and Th17 Development via Reduced NF-κB and Increased STAT5 Signals
por: Iguchi-Hashimoto, Mikiko, et al.
Publicado: (2011)

Clinical uses of GM-CSF, a critical appraisal and update
por: Arellano, Martha, et al.
Publicado: (2008)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020)

Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders
por: Murakami, Kosaku, et al.
Publicado: (2018)

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody
por: Papp, K.A., et al.
Publicado: (2018)

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
por: Ataya, Ali, et al.
Publicado: (2021)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

An update on GM-CSF and its potential role in melanoma management
por: O Dillman, Robert
Publicado: (2020)

Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)
por: Gajewska, Marta E., et al.
Publicado: (2018)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
por: Lang, Frederick M., et al.
Publicado: (2020)

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
por: Joshi, Ila, et al.
Publicado: (2023)

IL-17A(+)GM-CSF(+) Neutrophils Are the Major Infiltrating Cells in Interstitial Lung Disease in an Autoimmune Arthritis Model
por: Kwon, Oh Chan, et al.
Publicado: (2018)

Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis
por: Munsif, Maitri, et al.
Publicado: (2023)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

GM-CSF targeting in COVID-19: an approach based on fragile foundations
por: Kohler, Katharina, et al.
Publicado: (2023)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

Cell-free Fc-γ receptors IIIb, autoantibodies and related immune complexes trigger the production of G-CSF and GM-CSF in nonorgan-specific autoimmune diseases
por: Durand, V, et al.
Publicado: (2002)

GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
por: Sonderegger, Ivo, et al.
Publicado: (2008)

JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes
por: Shao, Shuai, et al.
Publicado: (2023)

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity
por: Tenbusch, Matthias, et al.
Publicado: (2008)

STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation
por: Sheng, Wanqiang, et al.
Publicado: (2014)

Anti-Fcgamma receptor (FcgammaR) autoantibodies (Ab) delay apoptosis of polymorphonuclear cells (PMN) in systemic autoimmune diseases by inducing the production of G-CSF and GM-CSF
por: Durand, V, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_id9spjv79jv1cmh19qeeq9k2d8